Every Form 4 that United Compute Inc (SHPH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SHPH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SHPH filings page.
HRT Financial LP, a ten percent owner of Shuttle Pharmaceuticals Holdings, Inc., reported open-market sales of a total of 83,149 shares of Common Stock. The sales on July 13–14, 2026 were executed at $4.67 and $4.48 per share, leaving no directly held shares of this security after the transactions.
HRT Financial LP, a ten percent owner of Shuttle Pharmaceuticals Holdings, Inc., reported two open-market purchases of common stock. On July 9, 2026 it bought 8,266 shares at $3.38 per share, and on July 10, 2026 it bought 731 shares at $3.11 per share. Following these transactions, HRT Financial LP directly held 61,271 shares of Shuttle Pharmaceuticals common stock.
HRT Financial LP, a ten percent owner of Shuttle Pharmaceuticals Holdings, Inc., reported selling a total of 29,111 shares of common stock in early July. It sold 18,531 shares on July 8 at $3.52 per share and 10,580 shares on July 7 at $3.33 per share in open-market transactions.
After these sales, HRT Financial LP directly holds 52,274 shares of Shuttle Pharmaceuticals common stock. The filing shows straightforward open-market sales with no derivative exercises or related derivative positions reported.
Shuttle Pharmaceuticals Holdings, Inc. reported that significant shareholder HRT Financial LP made offsetting trades in its common stock. On July 2, HRT Financial LP executed an open-market purchase of 7,851 shares at $3.54 per share. On July 6, it executed an open-market sale of 9,022 shares at $3.51 per share, resulting in a modest net reduction of its position. Following these transactions, HRT Financial LP directly held 81,385 shares of Shuttle Pharmaceuticals common stock.
HRT FINANCIAL LP, a ten percent owner of Shuttle Pharmaceuticals Holdings, Inc., reported an open-market purchase of common stock. On July 1, 2026, it bought 3,959 shares of Shuttle common stock at $3.30 per share. After this transaction, HRT FINANCIAL LP directly owns 82,556 shares of Shuttle common stock.
HRT Financial LP, a ten percent owner of Shuttle Pharmaceuticals Holdings, Inc., reported two open-market purchases of common stock. It bought 25,836 shares at $3.44 per share on June 29 and 6,755 shares at $3.23 per share on June 30. After these trades, HRT Financial LP directly holds 78,597 shares of Shuttle Pharmaceuticals common stock.